1173158-26-3

Basic information

• Product Name: 3-{4-[(prop-2-enyloxycarbonylamino)methyl]phenyl}propanoic acid
• Synonyms: 3-{4-[(prop-2-enyloxycarbonylamino)methyl]phenyl}propanoic acid
• CAS NO: 1173158-26-3
• Molecular Weight: 263.293
• Mol File: 1173158-26-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-{4-[(prop-2-enyloxycarbonylamino)methyl]phenyl}propanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-{4-[(prop-2-enyloxycarbonylamino)methyl]phenyl}propanoic acid(1173158-26-3)
• EPA Substance Registry System: 3-{4-[(prop-2-enyloxycarbonylamino)methyl]phenyl}propanoic acid(1173158-26-3)

Safety Data

• Hazardous Substances Data: 1173158-26-3(Hazardous Substances Data)

Upstream product

• 16642-94-7 (E)-4-cyanocinnamic acid 
• 55197-36-9 3-(4-aminomethyl-phenyl)-propionic acid 
• 2937-50-0 Allyl chloroformate 

Downstream Products

• 1173158-31-0 N-{[4-(3-hydroxypropyl)phenyl]methyl}prop-2-enyloxycarboxamide 
• 1173158-33-2 N-({4-[3-(aminooxy)propyl]phenyl}methyl)prop-2-enyloxycarboxamide hydrochloric acid salt 
• 1173158-41-2 C₃₀H₃₈N₄O₆ 
• 1173158-39-8 (2R)-N-{3-[4-(aminomethyl)phenyl]propoxy}-2-[(tert-butoxy)carbonylamino]-3-indol-3-ylpropanamide trifluoroacetic acid salt 
• 1173158-42-3 C₅₆H₈₇N₇O₁₃ 
• 1173156-15-4 2-{[2-({[N-({4-[3-((2R)-2-amino-3-indol-3-ylpropanoylaminooxy)propyl]phenyl}methyl)carbamoyl]methyl}{2-[bis(carboxymethyl)amino]ethyl}amino)ethyl](carboxymethyl)amino}acetic acid trifluoroacetic acid salt 
• 1173158-45-6 C₂₉H₃₉N₃O₆ 
• 1173158-44-5 (2R)-N-{3-[4-(aminomethyl)phenyl]propoxy}-2-[(tert-butoxy)carbonylamino]-4-phenylbutanamide trifluoroacetic acid salt 
• 1173158-46-7 C₅₅H₈₈N₆O₁₃ 
• 1173156-17-6 2-{[2-({[N-({4-[3-((2R)-2-amino-4-phenylbutanoylaminooxy)propyl]phenyl}methyl)carbamoyl]methyl}{2-[bis(carboxymethyl)amino]ethyl}amino)ethyl](carboxymethyl)amino}acetic acid trifluoroacetic acid salt 

Relevant articles and documents

N-ALKOXYAMIDE CONJUGATES AS IMAGING AGENTS

The present disclosure is directed to compounds, diagnostic agents, and related methods. In some cases, methods for treating patients are provided. More specifically, the disclosure provides compounds, diagnostic agents, and kits for detecting and/or imaging and/or monitoring elastin rich tissues. In addition, the disclosure provides methods of detecting and/or imaging and/or monitoring the presence of coronary plaque, carotid plaque, iliac/femoral plaque, aortic plaque, renal artery plaque, plaque of any arterial vessel, aneurism, vasculitis, other diseases of the arterial wall, and/or damage or structural changes in ligaments, uterus, lungs or skin, as indicated by changes in total vessel wall area, internal lumen size, and exterior arterial perimeter.

N-ALKOXYAMIDE CONJUGATES AS IMAGING AGENTS

The present disclosure is directed to compounds, diagnostic agents, and related methods. In some cases, methods for treating patients are provided. More specifically, the disclosure provides compounds, diagnostic agents, and kits for detecting and/or imaging and/or monitoring elastin rich tissues. In addition, the disclosure provides methods of detecting and/or imaging and/or monitoring the presence of coronary plaque, carotid plaque, iliac/femoral plaque, aortic plaque, renal artery plaque, plaque of any arterial vessel, aneurism, vasculitis, other diseases of the arterial wall, and/or damage or structural changes in ligaments, uterus, lungs or skin, as indicated by changes in total vessel wall area, internal lumen size, and exterior arterial perimeter.